戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 -OIT-FDEIA groups, except for level of total serum immunoglobulin E.
2                                              Serum immunoglobulin E against eight common inhalant and
3 d with asthma phenotypes, such as high total serum immunoglobulin E and bronchial hyperresponsiveness
4                                        Total serum immunoglobulin E and FEV1 predicted levels were no
5 ti-TNF-alpha-treated mice exhibited elevated serum immunoglobulin E and inhibition of the anticryptoc
6 ormed with asthma, AHR, lung function, total serum immunoglobulin E, and blood eosinophil levels.
7 levels at year 1 and repeated assessments of serum immunoglobulin E antibodies (year 1, 4.5, 6), atop
8  the allergen specificity, allergen-specific serum immunoglobulin E concentration, or individual labo
9                            Allergen-specific serum immunoglobulin E concentrations ranged from 0.1 to
10  and had higher blood eosinophil numbers and serum immunoglobulin E concentrations that were specific
11                            Allergen-specific serum immunoglobulin E detection and quantification have
12                            Allergen-specific serum immunoglobulin E determination with the fluoroimmu
13 e of type 2 (T2)-low asthma (i.e., low total serum immunoglobulin E, fractional exhaled nitric oxide,
14 sponses, characterized by increases in total serum immunoglobulin E (IgE) and specific serum IgG1 lev
15                                        While serum immunoglobulin E (IgE) concentration has been show
16                                     Elevated serum Immunoglobulin E (IgE) levels and increased airway
17  This study examined the association between serum immunoglobulin E (IgE) levels for a panel of commo
18                                        Total serum immunoglobulin E (IgE) levels were significantly l
19 al hyperresponsiveness (BHR), elevated total serum immunoglobulin E (IgE) levels, and skin tests posi
20 dies of intermediate phenotypes, one each on serum immunoglobulin E (IgE) levels, blood eosinophil co
21                                        Total serum immunoglobulin E (IgE) levels, for example, show s
22 ent of CD4-CD8- peripheral T cells, elevated serum immunoglobulin E (IgE), and possible pulmonary inf
23 cts on markers of Th2 inflammation, reducing serum immunoglobulin E (IgE), chemokine ligands 13 and 1
24 However, the level of a systemic Th2 marker, serum immunoglobulin E (IgE), correlated significantly w
25 ypersensitivity (DTH) to SEA; high levels of serum immunoglobulin E (IgE); a strong T2 cytokine pheno
26 nome-scan data set and incorporate the total serum immunoglobulin E level in the analysis.
27 ility of severe AD was associated with total serum immunoglobulin E levels greater than 1708 IU/mL an
28                                              Serum immunoglobulin E levels were increased in IL-13Ral
29 eukin-4 production by NKT cells, to increase serum immunoglobulin E levels, and to promote the genera
30  cytokine production, eosinophil influx, and serum immunoglobulin E levels.
31 so had reduced T2 cytokine production and no serum immunoglobulin E production.
32 action and positive peanut skin prick and/or serum immunoglobulin E testing.
33  measures included biological markers (total serum immunoglobulin E (tIgE), number of positive skin p
34 he accumulation of eosinophils and levels of serum immunoglobulin E were increased in NFAT1 -/- mice.